Dr Loretta A Pratt, MD | |
1850 E Park Ave, Suite 312, State College, PA 16803-6706 | |
(814) 237-6600 | |
(814) 237-5383 |
Full Name | Dr Loretta A Pratt |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 42 Years |
Location | 1850 E Park Ave, State College, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770583320 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD21694 (Maine) | Secondary |
207N00000X | Dermatology | 1577481 (New York) | Secondary |
207N00000X | Dermatology | MD038745E (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southern Maine Health Care | Biddeford, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Chadds Ford Dermatology, Pc | 1759454192 | 3 |
Arthur K. Balin, Md, Phd, Pc | 9739166547 | 2 |
Mainehealth | 7517860588 | 2067 |
News Archive
The winners of the American Society for Biochemistry and Molecular Biology annual awards will give lectures at the Experimental Biology 2011 conference April 9-13 at the Walter E. Washington Convention Center in Washington, D.C.
For avid runners, training for the next marathon never stops. While it's important to focus on running faster or farther, Houston Methodist physicians encourage runners to expand their training regimen and are providing the following tips for training and protecting the entire body.
Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.
› Verified 8 days ago
Entity Name | Arthur K. Balin, Md, Phd, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154366557 PECOS PAC ID: 9739166547 Enrollment ID: O20040630000472 |
News Archive
The winners of the American Society for Biochemistry and Molecular Biology annual awards will give lectures at the Experimental Biology 2011 conference April 9-13 at the Walter E. Washington Convention Center in Washington, D.C.
For avid runners, training for the next marathon never stops. While it's important to focus on running faster or farther, Houston Methodist physicians encourage runners to expand their training regimen and are providing the following tips for training and protecting the entire body.
Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.
› Verified 8 days ago
Entity Name | Chadds Ford Dermatology, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801083159 PECOS PAC ID: 1759454192 Enrollment ID: O20080718000253 |
News Archive
The winners of the American Society for Biochemistry and Molecular Biology annual awards will give lectures at the Experimental Biology 2011 conference April 9-13 at the Walter E. Washington Convention Center in Washington, D.C.
For avid runners, training for the next marathon never stops. While it's important to focus on running faster or farther, Houston Methodist physicians encourage runners to expand their training regimen and are providing the following tips for training and protecting the entire body.
Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Loretta A Pratt, MD 1850 E Park Ave, Suite 312, State College, PA 16803-6706 Ph: (814) 237-6600 | Dr Loretta A Pratt, MD 1850 E Park Ave, Suite 312, State College, PA 16803-6706 Ph: (814) 237-6600 |
News Archive
The winners of the American Society for Biochemistry and Molecular Biology annual awards will give lectures at the Experimental Biology 2011 conference April 9-13 at the Walter E. Washington Convention Center in Washington, D.C.
For avid runners, training for the next marathon never stops. While it's important to focus on running faster or farther, Houston Methodist physicians encourage runners to expand their training regimen and are providing the following tips for training and protecting the entire body.
Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.
› Verified 8 days ago
Timothy David Mckinley, Dermatology Medicare: Medicare Enrolled Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Dr. Cassandra Joy Simonetta, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 32 Colonnade Way, State College, PA 16803 Phone: 814-272-4445 Fax: 814-272-4450 | |
Jerry Forrest Mikesell, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1393 N Atherton St, State College, PA 16803 Phone: 814-238-6097 Fax: 814-238-5527 | |
Mary Amanda Jacobs, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr., State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Mark Edward Kozminsky, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2505 Green Tech Dr, Suite A1, State College, PA 16803 Phone: 814-237-6600 Fax: 814-237-5383 | |
Dr. Matthew Allyn Hazey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Scenery Dr Uppr Level, State College, PA 16801 Phone: 814-237-6600 Fax: 814-237-5383 |